Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,000
Closed -$1.09M 228
2025
Q3
$1.09M Hold
23,000
0.01% 101
2025
Q2
$1.11M Buy
23,000
+5,000
+28% +$255K 0.01% 98
2025
Q1
$998K Sell
18,000
-2,000
-10% -$108K 0.01% 96
2024
Q4
$965K Hold
20,000
0.01% 89
2024
Q3
$1.15M Sell
20,000
-4,000
-17% -$216K 0.01% 92
2024
Q2
$1.16M Buy
24,000
+4,000
+20% +$193K 0.01% 89
2024
Q1
$972K Hold
20,000
0.01% 105
2023
Q4
$995K Hold
20,000
0.01% 97
2023
Q3
$1.07M Hold
20,000
0.02% 96
2023
Q2
$1.08M Hold
20,000
0.01% 109
2023
Q1
$1.09M Buy
+20,000
New +$973K 0.02% 113
2022
Q3
Sell
-22,000
Closed -$1.1M 176
2022
Q2
$1.1M Hold
22,000
0.01% 133
2022
Q1
$1.13M Buy
+22,000
New +$1.14M 0.01% 134
2021
Q4
Sell
-12,000
Closed -$579K 240
2021
Q3
$579K Sell
12,000
-3,500
-23% -$178K 0.01% 167
2021
Q2
$816K Sell
15,500
-4,500
-23% -$235K 0.01% 159
2021
Q1
$989K Hold
20,000
0.01% 146
2020
Q4
$908K Sell
20,000
-10,000
-33% -$493K 0.01% 108
2020
Q3
$1.5M Buy
30,000
+9,250
+45% +$476K 0.03% 98
2020
Q2
$1.06M Buy
+20,750
New +$1.01M 0.02% 99

Other funds holding SNY

Clal Insurance's SNY Position: Q4 2025 in Review

Clal Insurance sold out of Sanofi (SNY) in Q4 2025, closing a stake of 23,000 shares — an estimated $1.09M sold.

Clal Insurance first reported a position in SNY in Q2 2020 and held it in 19 quarters. The position peaked at $1.5M in Q3 2020. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Clal Insurance reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Clal Insurance sold 23,000 Sanofi shares in Q4 2025, an estimated $1.09M.
  • Clal Insurance first reported a position in Sanofi in Q2 2020 and held it in 19 quarters.
  • Clal Insurance's Sanofi position peaked at $1.5M in Q3 2020.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Clal Insurance's 13F filing for Q4 2025, filed 13 Feb 2026.